Quick Answer
Verastem, Inc. reported Operating Income Loss of -$170.13 million for the year ending 2025.
- Verastem, Inc. showed a decrease of -48.0% in Operating Income Loss from 2024 to 2025.
- This data is from Verastem, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), Verastem, Inc.'s Operating Income Loss has declined by 1,142.0%.
- Historical annual values: Fiscal year 2025: -$170.13 million | Fiscal year 2024: -$114.96 million | Fiscal year 2023: -$92.08 million | Fiscal year 2022: -$72.94 million | Fiscal year 2021: -$61.41 million | Fiscal year 2020: -$49.36 million | Fiscal year 2019: -$132.34 million | Fiscal year 2018: -$94.78 million | Fiscal year 2017: -$67.80 million | Fiscal year 2016: -$37.00 million | Fiscal year 2015: -$58.20 million | Fiscal year 2014: -$53.61 million | Fiscal year 2013: -$41.40 million | Fiscal year 2012: -$32.23 million | Fiscal year 2011: -$13.70 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: